Arcturus Therapeutics Holdings (ARCT) Capital Expenditures (QoQ) (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) Capital Expenditures (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 386.00% |
| Sep 30, 2024 | -75.61% |
| Jun 30, 2024 | 36.67% |
| Mar 31, 2024 | -72.57% |
| Dec 31, 2023 | -39.61% |
| Sep 30, 2023 | 208.30% |
| Jun 30, 2023 | 339.25% |
| Mar 31, 2023 | -97.19% |
| Dec 31, 2022 | 74.15% |
| Sep 30, 2022 | 678.31% |
| Jun 30, 2022 | -117.91% |
| Mar 31, 2022 | 194.45% |
| Dec 31, 2021 | -226.56% |
| Sep 30, 2021 | 521.83% |
| Jun 30, 2021 | 19.33% |
| Mar 31, 2021 | 127.17% |
| Dec 31, 2020 | -187.51% |
| Sep 30, 2020 | 1,121.43% |
| Jun 30, 2020 | -169.01% |
| Mar 31, 2020 | -54.92% |